Senseonics Holdings, Inc. SENS
8.91 USD -0.84 (-8.57%)
Regular-session close
8.80 -0.10 -1.18%
Pre-market · Nov 20, 7:14 AM ET
8.76 Day range 10.15
4.79 52-week range 13.98
- YTD
- +61.32%
- 1 year
- +57.89%
News
zacks.com BBNX & SENS Launch Eversense 365 Integration With iLet Bionic Pancreas Beta Bionics launches iLet Bionic Pancreas integration with Eversense 365, offering more CGM options and boosting growth prospects in the diabetes care market.
globenewswire.com Senseonics and Beta Bionics Launch Eversense® 365 and iLet® Bionic Pancreas Integration Eversense 365 now works with iLet, combining a year of accurate glucose monitoring with fully adaptive, automated insulin delivery to reduce the demands of managing diabetesbenzinga.com Mizuho Maintains Outperform on Senseonics Holdings, Raises Price Target to $20 Mizuho analyst Anthony Petrone maintains Senseonics Holdings (NASDAQ:SENS) with a Outperform and raises the price target from $18 to $20.
benzinga.com TD Cowen Maintains Buy on Senseonics Holdings, Raises Price Target to $17 TD Cowen analyst Joshua Jennings maintains Senseonics Holdings (NASDAQ:SENS) with a Buy and raises the price target from $15 to $17.
benzinga.com Senseonics Stock Rises Tuesday on Strong Q3 Revenue, Raised 2026 Outlook Shares of Senseonics Holdings Inc (NASDAQ:SENS) are trading higher on Tuesday after the company reported better-than-expected third-quarter financial results and raised its fiscal 2026 revenue…
benzinga.com AAON, Ziprecruiter, Rackspace Technology, Babcock & Wilcox And Other Big Stocks Moving Higher On Tuesday U.S. stocks fell, but AAON surged 23% on strong earnings and raised guidance. ZipRecruiter, Securitize and Senseonics led other gainers.benzinga.com Stifel Reiterates Hold on Senseonics Holdings, Raises Price Target to $10 Stifel analyst Jonathan Block reiterates Senseonics Holdings (NASDAQ:SENS) with a Hold and raises the price target from $9 to $10.
benzinga.com Barclays Maintains Equal-Weight on Senseonics Holdings, Raises Price Target to $11 Barclays analyst Christopher Pasquale maintains Senseonics Holdings (NASDAQ:SENS) with a Equal-Weight and raises the price target from $10 to $11.
benzinga.com This Riot Platforms Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday Analysts upgraded RIOT, SENS, MSDL, SCCO and SECZ; RIOT’s price target jumped to $28, while MSDL’s target fell to $14.50.
benzinga.com 12 Health Care Stocks Moving In Tuesday's Pre-Market Session Gainers Co-Diagnostics (NASDAQ:CODX) stock moved upwards by 22.4% to $0.39 during Tuesday's pre-market session. The company's market cap stands at $2.8 million. As per the press release, Q3 earnings…benzinga.com HC Wainwright & Co. Reiterates Buy on Senseonics Holdings, Maintains $14 Price Target HC Wainwright & Co. analyst Sean Lee reiterates Senseonics Holdings (NASDAQ:SENS) with a Buy and maintains $14 price target.
benzinga.com Raymond James Upgrades Senseonics Holdings to Market Perform Raymond James analyst Jayson Bedford upgrades Senseonics Holdings (NASDAQ:SENS) from Underperform to Market Perform.
benzinga.com Senseonics Holdings Q3 2026 Earnings Call Transcript Senseonics Holdings (AMEX:SENS) reported third-quarter financial results on Monday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is brought to…benzinga.com Senseonics Holdings Raises FY2026 Sales Guidance from $62.000M-$66.000M to $68.000M-$70.000M vs $64.243M Est Senseonics Holdings (AMEX:SENS) raises FY2026 sales outlook from $62.000 million-$66.000 million to $68.000 million-$70.000 million vs $64.243 million estimate.
benzinga.com Senseonics Holdings Q3 EPS $(0.50) Beats $(0.52) Estimate, Sales $19.561M Beat $16.198M Estimate Senseonics Holdings (AMEX:SENS) reported quarterly losses of $(0.50) per share which beat the analyst consensus estimate of $(0.52) by 3.85 percent. This is a 16.28 percent decrease over losses of…
benzinga.com TD Cowen Reiterates Buy on Senseonics Holdings, Maintains $15 Price Target TD Cowen analyst Joshua Jennings reiterates Senseonics Holdings (NASDAQ:SENS) with a Buy and maintains $15 price target.
benzinga.com Senseonics Initiates First-In-Human Study Of Freedom First clinical evaluation of investigational, transmitter-free one-year CGM marks an important milestone on Senseonics’ innovation roadmap, with potential launch in 2028Built on the proven sensing…
